Literature DB >> 34981472

The Multifaceted Actions of Curcumin in Obesity.

Vanessa Bianconi1, Matteo Pirro1, Seyed Mohammad Hassan Moallem2, Muhammed Majeed3, Paola Bronzo1, Marco D'Abbondanza1, Tannaz Jamialahmadi4,5, Amirhossein Sahebkar6,7,8.   

Abstract

Obesity remains a pervasive health concern worldwide with concomitant comorbidities such as cardiovascular diseases, diabetes, inflammation, and other metabolic disorders. A wealth of data validates dietary and lifestyle modifications such as restricting caloric intake and increasing physical activity to slow the obesity development. Recently, the advent of phytochemicals such as curcumin, the active ingredient in turmeric, has attracted considerable research interest in tracking down their possible effects in protection against obesity and obesity-related comorbidities. According to the existing literature, curcumin may regulate lipid metabolism and suppress chronic inflammation interacting with white adipose tissue, which plays a central role in the complications associated with obesity. Curcumin also inhibits the differentiation of adipocyte and improves antioxidant properties. In the present review, we sought to deliberate the possible effects of curcumin in downregulating obesity and curtailing the adverse health effects of obesity.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Adiposity; Curcumin; Inflammation; Metabolism

Mesh:

Substances:

Year:  2021        PMID: 34981472     DOI: 10.1007/978-3-030-73234-9_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  76 in total

Review 1.  "Obesity paradox" in coronary artery disease.

Authors:  Ibrahim Akin; Christoph A Nienaber
Journal:  World J Cardiol       Date:  2015-10-26

2.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 3.  Obesity Epidemiology Worldwide.

Authors:  Cassandra Arroyo-Johnson; Krista D Mincey
Journal:  Gastroenterol Clin North Am       Date:  2016-12       Impact factor: 3.806

Review 4.  Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Paul Poirier; Thomas D Giles; George A Bray; Yuling Hong; Judith S Stern; F Xavier Pi-Sunyer; Robert H Eckel
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

Review 5.  Overview of epidemiology and contribution of obesity to cardiovascular disease.

Authors:  Marjorie Bastien; Paul Poirier; Isabelle Lemieux; Jean-Pierre Després
Journal:  Prog Cardiovasc Dis       Date:  2013-10-24       Impact factor: 8.194

Review 6.  Pathways from obesity to diabetes.

Authors:  J-P Felber; A Golay
Journal:  Int J Obes Relat Metab Disord       Date:  2002-09

Review 7.  Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?

Authors:  Taher Mandviwala; Umair Khalid; Anita Deswal
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

8.  Obesity epidemiology.

Authors:  Yarah M Haidar; Bard C Cosman
Journal:  Clin Colon Rectal Surg       Date:  2011-12

9.  Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006.

Authors:  Arupendra Mozumdar; Gary Liguori
Journal:  Diabetes Care       Date:  2010-10-01       Impact factor: 19.112

10.  The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies.

Authors:  Jana V van Vliet-Ostaptchouk; Marja-Liisa Nuotio; Sandra N Slagter; Dany Doiron; Krista Fischer; Luisa Foco; Amadou Gaye; Martin Gögele; Margit Heier; Tero Hiekkalinna; Anni Joensuu; Christopher Newby; Chao Pang; Eemil Partinen; Eva Reischl; Christine Schwienbacher; Mari-Liis Tammesoo; Morris A Swertz; Paul Burton; Vincent Ferretti; Isabel Fortier; Lisette Giepmans; Jennifer R Harris; Hans L Hillege; Jostein Holmen; Antti Jula; Jenny E Kootstra-Ros; Kirsti Kvaløy; Turid Lingaas Holmen; Satu Männistö; Andres Metspalu; Kristian Midthjell; Madeleine J Murtagh; Annette Peters; Peter P Pramstaller; Timo Saaristo; Veikko Salomaa; Ronald P Stolk; Matti Uusitupa; Pim van der Harst; Melanie M van der Klauw; Melanie Waldenberger; Markus Perola; Bruce Hr Wolffenbuttel
Journal:  BMC Endocr Disord       Date:  2014-02-01       Impact factor: 2.763

View more
  2 in total

1.  Curcumae Radix Decreases Neurodegenerative Markers through Glycolysis Decrease and TCA Cycle Activation.

Authors:  Seong-Lae Jo; Hyun Yang; Sang R Lee; Jun H Heo; Hye-Won Lee; Eui-Ju Hong
Journal:  Nutrients       Date:  2022-04-11       Impact factor: 6.706

2.  Curcumin Sensitises Cancerous Kidney Cells to TRAIL Induced Apoptosis via Let-7C Mediated Deregulation of Cell Cycle Proteins and Cellular Metabolism.

Authors:  Ismael Obaidi; Alfonso Blanco Fernández; Tara McMorrow
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.